Keyphrases
Inflammatory Bowel Disease
100%
Pharmacogenetics and Pharmacogenomics
100%
Adverse Effects
40%
NOD2 Gene
40%
Toll-like
20%
Clinical Manifestations
20%
Single nucleotide Polymorphism
20%
Crohn's Colitis
20%
Crohn's Disease
20%
Early Disease
20%
Patient-specific Therapy
20%
Armamentarium
20%
Myelosuppression
20%
Stenotic Lesion
20%
Enzymatic Activity
20%
Pharmacotherapy
20%
Hepatitis
20%
Immunomodulatory Therapy
20%
Surgical Intervention
20%
Disease Subtypes
20%
Aminosalicylates
20%
Immunomodulator
20%
Susceptibility Loci
20%
Medical Approach
20%
CARD15
20%
N-acetyltransferase 2 (NAT2)
20%
Penetrating Disease
20%
Methylase Genes
20%
Thiopurine Methyltransferase
20%
Fibrostenotic Disease
20%
Medicine and Dentistry
Disease
100%
Pharmacogenetics
100%
Inflammatory Bowel Disease
100%
Pharmacogenomics
100%
Adverse Event
40%
Crohn's Disease
40%
Low Drug Dose
20%
Drug Therapy
20%
Surgery
20%
Single Nucleotide Polymorphism
20%
Ulcerative Colitis
20%
Toll Like Receptor 4
20%
Bone Marrow Suppression
20%
Immunomodulating Agent
20%
Enzyme Activity
20%
Thiopurine Methyltransferase
20%
Caspase Recruitment Domain Protein 15
20%
Biochemistry, Genetics and Molecular Biology
Pharmacogenomics
100%
Pharmacogenetics
100%
NOD2
100%
Genetics
50%
Low Drug Dose
50%
Enzyme Activity
50%
Single-Nucleotide Polymorphism
50%
N-Acetyltransferase
50%
TLR4
50%
Thiopurine Methyltransferase
50%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Pharmacogenomics
100%
Pharmacogenetics
100%
Inflammatory Bowel Disease
100%
Adverse Event
40%
Crohn's Disease
40%
Pharmacotherapy
20%
Ulcerative Colitis
20%
Toll Like Receptor 4
20%
Bone Marrow Suppression
20%
Immunomodulating Agent
20%
Thiopurine Methyltransferase
20%
Caspase Recruitment Domain Protein 15
20%
Immunology and Microbiology
Pharmacogenomics
100%
Inflammatory Bowel Disease
100%
Pharmacogenetics
100%
Crohn's Disease
40%
NOD2
40%
Single Nucleotide Polymorphism
20%
TLR4
20%
Low Drug Dose
20%
Enzyme Activity
20%
Immunomodulating Drugs
20%
Ulcerative Colitis
20%
Neuroscience
Inflammatory Bowel Disease
100%
Adverse Effect
40%
Single-Nucleotide Polymorphism
20%
TLR 4
20%
Immunomodulating Drugs
20%
Enzyme Activity
20%
N-Acetyltransferase
20%
Thiopurine Methyltransferase
20%
Caspase Recruitment Domain Protein 15
20%